Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989-2006

European Journal of Cancer

Volumn 46, Issue 11, 2010, Pages 2077-2087

  Cremers, R G H M ^a   Karim Kos, H E ^b   Houterman, S ^c   Verhoeven, R H A ^d   Schroder F H ^e   Van Der Kwast, T H ^f   Kil, P J M ^g   Coebergh, J W W ^b,d   Kiemeney, L A L M ^a,h  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d Eindhoven Cancer Registry   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^h Integraal Kankercentrum Oost   (Netherlands)

Author keywords

Incidence; Mortality; Prostate cancer; Prostate specific antigen; Survival; Trend analysis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AWARENESS; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TREND STUDY;

AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; MALE; MORTALITY; NETHERLANDS; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 77954213192     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.03.040     Document Type: Article

References (36)

1. H. Gronberg Prostate cancer epidemiology Lancet 361 9360 2003 859 864
2. A.L. Potosky, L. Kessler, G. Gridley, C.C. Brown, and J.W. Horm Rise in prostatic cancer incidence associated with increased use of transurethral resection J Natl Cancer Inst 82 20 1990 1624 1628
3. F. Lee, J.M. Gray, and R.D. McLeary Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology, and staging Prostate 7 2 1985 117 129
4. F. Lee, P.J. Littrup, and R.D. McLeary Needle aspiration and core biopsy of prostate cancer: comparative evaluation with biplanar transrectal US guidance Radiology 163 2 1987 515 520
5. T.A. Stamey, N. Yang, and A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 15 1987 909 916
6. M. Quinn, and P. Babb Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons BJU Int 90 2 2002 162 173 (Pubitemid 34779587)
7. H.G. Welch, and P.C. Albertsen Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 J Natl Cancer Inst 101 19 2009 1325 1329
8. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 13 2009 1320 1328
9. Statistics Netherlands. Permanent research into the living situation - health inquiry (POLS) (Dutch).
10. A.B. Jani, and S. Hellman Early prostate cancer: clinical decision-making Lancet 361 9362 2003 1045 1053
11. Netherlands Cancer Registry. NCR data - incidence data. [accessed 27.1.2010].
12. S. Siesling, J.A. van Dijck, O. Visser, and J.W. Coebergh Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998 Eur J Cancer 39 17 2003 2521 2530
13. P.N. Post, P.J. Kil, M.A. Crommelin, R.F. Schapers, and J.W. Coebergh Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995 Eur J Cancer 34 5 1998 705 709
14. Statistics Netherlands. Mortality data. [accessed 27.1.2010].
15. Percy C, Fritz A, Jack A, et al. International classification of diseases for oncology (ICD-O-3), 3rd ed. Geneva: WHO; 2000.
16. D.F. Gleason, and G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 1 1974 58 64
17. L. Sobin, and C. Wittekind TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
18. H.J. Kim, M.P. Fay, E.J. Feuer, and D.N. Midthune Permutation test for joinpoint regression with applications to cancer rates Stat Med 19 2000 335 351
19. T. Hakulinen, and K.H. Abeywickrama A computer program package for relative survival analysis Comput Programs Biomed 19 2-3 1985 197 207
20. H. Brenner, and O. Gefeller An alternative approach to monitoring cancer patient survival Cancer 78 9 1996 2004 2010
21. R.W. Giard, J.W. Coebergh, and V.I. Casparie-van A marked increase in the rate of diagnosed prostate cancer in the Netherlands during 1990-1996 Ned Tijdschr Geneeskd 142 35 1998 1958 1962
22. A.L. Potosky, B.A. Miller, P.C. Albertsen, and B.S. Kramer The role of increasing detection in the rising incidence of prostate cancer JAMA 273 7 1995 548 552
23. S.J. Otto, I. van dC, and M.K. Liem Effective PSA contamination in the Rotterdam section of the European randomized study of screening for prostate cancer Int J Cancer 105 3 2003 394 399
24. S.M. Collin, R.M. Martin, and C. Metcalfe Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study Lancet Oncol 9 5 2008 445 452
25. J. Melia, S. Moss, and L. Johns Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study BJU Int 94 1 2004 51 56
26. H.E. Karim-Kos, V.E. de, and I. Soerjomataram Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 10 2008 1345 1389
27. O. Visser, S. Siesling, and J.A.A.M. van Dijck Incidence of cancer in the Netherlands 1999/2000 2003 Vereniging van Integrale Kankercentra Utrecht
28. Horner MJ, Ries LAG, Krapcho M, et al. SEER cancer statistics review; 1975-2006. [accessed 27.1.2010].
29. R.M. Merrill, and C.L. Wiggins Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate Urol Oncol 7 5 2002 213 219
30. M. Bolla, D. Gonzalez, and P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 5 1997 295 300
31. Statistics Netherlands. Survival data. [accessed 27.1.2010].
32. J.I. Epstein Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made Am J Surg Pathol 24 4 2000 477 478
33. J.I. Epstein, W.C. Allsbrook Jr, M.B. Amin, and L.L. Egevad The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 9 2005 1228 1242
34. A. Billis, M.S. Guimaraes, and L.L. Freitas The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies J Urol 180 2 2008 548 552
35. C. Bouchardy, G. Fioretta, and E. Rapiti Recent trends in prostate cancer mortality show a continuous decrease in several countries Int J Cancer 123 2008 421 429
36. F. Levi, F. Lucchini, E. Negri, P. Boyle, and V.C. La Changed trends of cancer mortality in the elderly Ann Oncol 12 10 2001 1467 1477